- BMRN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $115.2 million.
- BMRN is up 2.3% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in BMRN with the Ticky from Trade-Ideas. See the FREE profile for BMRN NOW at Trade-Ideas More details on BMRN: BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. Currently there are 12 analysts that rate Biomarin Pharmaceutical a buy, no analysts rate it a sell, and 4 rate it a hold. The average volume for Biomarin Pharmaceutical has been 1.2 million shares per day over the past 30 days. Biomarin has a market cap of $13.3 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.16 and a short float of 3.6% with 3.75 days to cover. Shares are up 28.2% year-to-date as of the close of trading on Tuesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.